RAGE is a Potential Cause of Onset and Progression of Nonalcoholic Fatty Liver Disease by Kamyar Asadipooya, Kamran B. Lankarani, Rishi Raj, Mohammadreza Kalantarhormozi

“…Fatty liver is a rising global health concern, significantly increasing the burden of health care cost. Nonalcoholic fatty liver disease (NAFLD) has a correlation with metabolic syndrome and its complications. …”
Get full text

Inter-organ metabolic interaction networks in non-alcoholic fatty liver disease by Yu-Hong Fan, Siyao Zhang, Ye Wang, Hongni Wang, Hongliang Li, Hongliang Li, Hongliang Li, Lan Bai

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Metabolic associated fatty liver disease and COVID-19: a double whammy? by Jaime Hui Xian Lin, Veeraraghavan Meyyur Aravamudan

Get full text

Transcriptome analysis of liver injury of fatty liver disease induced by ALDH2 deficiency by Ziying Xu, Yagang Gao, Zihui Yu, Rui Zhang, Ruikun Wang, Shang Li, Shuowen Wang, Bing Du, Ziyan Tian, Lijuan Huang, Zanbo Ding, Jing Yuan

Subjects: Get full text

Serum Calcium and Phosphorus Concentration in Egyptian Patients with Non-Alcoholic Fatty liver disease by Mohammed F. Mohammed, Sameh S.E. Elsayed, Asem G. Yosuf

Subjects: Get full text

Understanding the Role of Exercise in Nonalcoholic Fatty Liver Disease: ERS-Linked Molecular Pathways by Yong Zou, Zhengtang Qi

“…Nonalcoholic fatty liver disease (NAFLD) is globally prevalent and characterized by abnormal lipid accumulation in the liver, frequently accompanied by insulin resistance (IR), enhanced hepatic inflammation, and apoptosis. …”
Get full text

Acute Coronary Syndromes and Nonalcoholic Fatty Liver Disease: “Un Affaire de Coeur” by Abdulrahman Ismaiel, Stefan-Lucian Popa, Dan L. Dumitrascu

“…Both nonalcoholic fatty liver disease (NAFLD) and ischemic heart disease have common pathogenic links. …”
Get full text

Profile of Children With Non-alcoholic Fatty Liver Disease Referred to a Hospital in Iran by Amin Ghanbari, Mohammadreza Pazoki, Bahar Allahverdi, Pejman Rohani, Parisa Rahmani

Subjects: “…non-alcoholic fatty liver disease (nafld)…”
Get full text

Metabolic and Genetic Determinants of Lipid Metabolism Disruption in Non-Alcoholic Fatty Liver Disease by O. Yu. Kytikova, T. P. Novgorodtseva, Yu. K. Denisenko, D. A. Kovalevsky

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease by Hongjie Ou, Yaojie Fu, Wei Liao, Caixia Zheng, Xiaolu Wu

“…We aimed at analyzing the role of smoking in hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) and at exploring the related risk factors. …”
Get full text

Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease by Emmanouil Nychas, Andrea Marfil-Sánchez, Xiuqiang Chen, Mohammad Mirhakkak, Huating Li, Weiping Jia, Aimin Xu, Henrik Bjørn Nielsen, Max Nieuwdorp, Rohit Loomba, Yueqiong Ni, Gianni Panagiotou

“…Abstract Background The pathogenesis of non-alcoholic fatty liver disease (NAFLD) with a global prevalence of 30% is multifactorial and the involvement of gut bacteria has been recently proposed. …”
Get full text

Effects of Pioglitazone on Nonalcoholic Fatty Liver Disease in the Absence of Constitutive Androstane Receptor Expression by Hwa Young Ahn, Hwan Hee Kim, Ji-Yeon Hwang, Changhun Park, Bo Youn Cho, Young Joo Park

“…Nonalcoholic fatty liver disease or steatohepatitis (NAFLD/NASH) is a fatty liver disease that is closely related to obesity, diabetes, and dyslipidemia. …”
Get full text

Impact of hypertension on liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease by Zhifeng Gao, Huan Deng, Bowen Qin, Liang Bai, Jiangwei Li, Jian Zhang

Get full text

Association of GCKR and MBOAT7 genetic polymorphisms with non-alcoholic fatty liver disease by Swati U. Chavan, Pravin Rathi, Ameet Mandot

Get full text

Osteocalcin Alleviates Nonalcoholic Fatty Liver Disease in Mice through GPRC6A by Mingliang Zhang, Xiaomin Nie, Yeqing Yuan, Yansu Wang, Xiaojing Ma, Jun Yin, Yuqian Bao

“…Previous studies have found that treatment with uncarboxylated osteocalcin can protect mice from high-fat diet-induced nonalcoholic fatty liver disease (NAFLD). However, the potential mechanisms remain unclear. …”
Get full text

Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients by Julia Uhanova, Gerald Minuk, Federico Lopez Ficher, Natasha Chandok

“…Features of nonalcoholic fatty liver disease (NAFLD) have yet to be described in the Canadian First Nations (FN) population. …”
Get full text

Comment on “Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp” by Davide Giuseppe Ribaldone, Giorgio Maria Saracco, Rinaldo Pellicano

Get full text

Intrahepatic Cholestasis in Non-Alcoholic Fatty Liver Disease: Pathogenesis and Role of Ademetionine in Treatment by Ye. N. Shirokova

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease by Sun Xin, Zhang Yan, Xie Meilin

Subjects: “…non alcoholic fatty liver disease…”
Get full text

Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease by Kouichi Miura, Ekihiro Seki, Hirohide Ohnishi, David A. Brenner

“…Activation of innate immunity is associated with the development of liver disease, including non-alcoholic fatty liver disease (NAFLD). In the innate immune system, Toll-like receptors (TLRs) are sensors that recognize bacterial and viral components such as lipopolysaccharide, bacterial DNA, and peptidoglycan. …”
Get full text